| 000 | 01437 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518005415.0 | ||
| 264 | 0 | _c20181211 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1744-7658 | ||
| 024 | 7 |
_a10.1080/13543784.2018.1543398 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGreco, Marco | |
| 245 | 0 | 0 |
_aInvestigational small molecules in phase II clinical trials for the treatment of epilepsy. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _c12 2018 |
||
| 300 |
_a971-979 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xpharmacology |
| 650 | 0 | 4 |
_aCannabinoids _xpharmacology |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aDrug Resistant Epilepsy _xdrug therapy |
| 650 | 0 | 4 |
_aDrugs, Investigational _xpharmacology |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPregnanolone _xanalogs & derivatives |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aQuinazolinones _xpharmacology |
| 700 | 1 | _aVarriale, Gaia | |
| 700 | 1 | _aCoppola, Giangennaro | |
| 700 | 1 | _aOperto, Francesca | |
| 700 | 1 | _aVerrotti, Alberto | |
| 700 | 1 | _aIezzi, Maria Laura | |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 27 _gno. 12 _gp. 971-979 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/13543784.2018.1543398 _zAvailable from publisher's website |
| 999 |
_c29024276 _d29024276 |
||